Crotedumab (REGN1193) is a humanized antibody targeting GCGR, which reduces fasting blood glucose and improves glucose tolerance, used in diabetes research.
Purity:
>95%
CAS Number:
[1452387-69-7]
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted